Skip to content

13F-HR filed by Summit Rock Advisors, LP

Summit Rock Advisors, LP filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-12, with 10 holding rows worth $286,745,000.

Accession
0001172661-21-000387
Filed
2021-02-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 10 entries on the cover page, a total value of $286,745,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $286,745,000 with VALUE read as thousands by filing date, 13F file number 028-14655. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Vanguard Total World Stock ETF922042742SHS1,104,408$102,246,000thousands by filing date
Vanguard FTSE All-World ex-US Small-Cap ETF922042718SHS487,765$59,429,000thousands by filing date
iShares Core S&P U.S. Value ETF464287663SHS726,403$45,175,000thousands by filing date
ISHARES TR464288513IBOXX HI YD ETF414,440$36,181,000thousands by filing date
ISHARES TR46435G102CONV BD ETF172,253$16,631,000thousands by filing date
VANGUARD WORLD FD921910709EXTENDED DUR97,773$14,891,000thousands by filing date
INVESCO EXCH TRADED FD TR II46138G508SR LN ETF467,191$10,409,000thousands by filing date
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK34,350$1,141,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM14,891$384,000thousands by filing date
GENERATION BIO CO37148K100COM9,113$258,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-21-000387this filing2021-02-12acceptance time not in the bulk data set